@FiercePharma: That $2B to $3B deal size is Big Pharma's sweet spot: Novartis, Roche and now Sanofi say so. Story | Follow @FiercePharma
> Sanofi ($SNY) CEO Christopher Viehbacher told The Boston Globe that the company will trim $170 million in annual costs as it absorbs Genzyme, the rare-disease specialist it bought last year. More
> Novartis ($NVS) said its multiple sclerosis pill Gilenya hit its target in a late-stage trial testing its ability to stave off a relapse in symptoms, with Gilenya patients 48% less likely to relapse than placebo patients. News
> Andrew Lansley, CEO of the U.K. cost-effectiveness watchdog NICE, pledged to require all National Health Service trusts to provide agency-approved drugs to patients who need them, ending so-called "postcode prescribing." Report
> FDA received applications for generic versions of three HIV-fighting drugs: Merck's ($MRK) Isentress, GlaxoSmithKline's ($GSK) Epivir and Bayer's Beyaz. More
> A new strain of tuberculosis that's resistant to all drugs used to fight the disease has emerged in India, local media reports. Article
Biotech News
@FierceBiotech: CRO consolidation to slow in 2012, Icon CEO says. More | Follow @FierceBiotech
@JohnCFierce: It's good to be the CEO, says BMS chief Lamberto Andreotti at #JPM12. Give him his due, he earned it. Story | Follow @JohnCFierce
@MaureenFierce: Researchers develop tech to detect inherited MPS disorders. Article | Follow @MaureenFierce
@RyanMFierce: AstraZeneca taps IMS Health to mine outcomes data, electronic health records and to develop analysis platform. News | Follow @RyanMFierce
@MarkHFierce: It seems that nanotech delivery advances are getting serious already in 2012. | Follow @MarkHFierce
> Early-stage biotech investor Flagship launches $270M fund. Article
> Sanofi deal strategy will shun hep C in global hunt for new 'pearls.' More
> Actelion braces for looming pivotal data on blockbuster macitentan program. Story
> Bristol CEO touts successful biopharma blitz after big hep C play. News
Medical Device News
> Ishrak: Medtronic has eyes on overseas acquisitions. Item
> Ventana, Pfizer, CST collaborate on NSCLC companion diagnostic. Article
> Medical imaging company NeuroLogica grabs $12M in funding. Story
> Active Implants rakes in $10M in financing round. News
> Olympus brings suit against current, former execs over accounting scandal. More
Drug Delivery News
> Nanotech penetrates prostate cancer cells armed with chemo drugs. Story
> Endo grabs BDSI's drug film chronic pain treatment through global license. Article
> Novel nanoparticles penetrate fruit flies' brains; people's may be next. More
> Civitas' inhaled L-dopa Parkinson's treatment passes Phase I. News
Biomarkers News
> Early blood test could predict baby's sex. News
> Researchers find new lung cancer biomarkers. More
> As genome sequences get cheaper, is more always better? Article
> Immune biomarker could link to autism. Story
And Finally... Psoriasis sufferers may be at a greater risk of blocked arteries, a new study finds. Report